Literature DB >> 19075043

Distinct functions of vascular endothelial and smooth muscle PPARgamma in regulation of blood pressure and vascular tone.

Ningning Wang1, J David Symons, Hui Zhang, Zhanjun Jia, Frank J Gonzalez, Tianxin Yang.   

Abstract

Thiazolidinediones (TZDs) are peroxisome proliferators-activated receptor gamma (PPARgamma) activators that exhibit antihypertensive and vasculo-protective effects. Here we describe the use of Tie2Cre/flox and SM22Cre/flox mice, which respectively lacked PPARgamma in the endothelium and the smooth muscle, to study vascular function of PPARgamma. Rosiglitazone (RGZ) induced a similar blood pressure (BP)-lowering effect in deoxycorticosterone acetate (DOCA) salt-treated PPARgamma(f/f) and SM22Cre/flox mice, whereas Tie2Cre/flox mice were completely resistant to this effect. The femoral arteries lacking endothelial PPARgamma exhibited increased reactivity to various vasoconstrictors without a significant alteration in acetylcholine-induced relaxation. In sharp contrast, the vasculature lacking smooth muscle PPARgamma had blunted sensitivity to alpha1-adrenergic agents but enhanced sensitivity to acetylcholine. Our results demonstrated endothelium but not smooth muscle as the site for TZD-induced BP-lowering effect and also uncovered distinct functions of endothelial and smooth muscle PPARgamma in regulation of vascular tone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19075043      PMCID: PMC2791342          DOI: 10.1177/0192623308328545

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  37 in total

1.  Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate.

Authors:  J David Symons; John C Rutledge; U Simonsen; Roshny A Pattathu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-02       Impact factor: 4.733

2.  PPARgamma in endothelial cells influences high fat diet-induced hypertension.

Authors:  Christopher J Nicol; Masahiro Adachi; Taro E Akiyama; Frank J Gonzalez
Journal:  Am J Hypertens       Date:  2005-04       Impact factor: 2.689

3.  Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

Authors:  Hui Zhang; Aihua Zhang; Donald E Kohan; Raoul D Nelson; Frank J Gonzalez; Tianxin Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

4.  Restricted inactivation of serum response factor to the cardiovascular system.

Authors:  Joseph M Miano; Narendrakumar Ramanan; Mary A Georger; Karen L de Mesy Bentley; Rachael L Emerson; Robert O Balza; Qi Xiao; Hartmut Weiler; David D Ginty; Ravi P Misra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

5.  Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia.

Authors:  Lakshmi S Tallam; David E Stec; Mary A Willis; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2005-07-18       Impact factor: 10.190

6.  Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats.

Authors:  Jian Song; Mark A Knepper; Xinqun Hu; Joseph G Verbalis; Carolyn A Ecelbarger
Journal:  J Pharmacol Exp Ther       Date:  2003-10-30       Impact factor: 4.030

7.  Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk.

Authors:  Yihong Wan; Alan Saghatelian; Ling-Wa Chong; Chun-Li Zhang; Benjamin F Cravatt; Ronald M Evans
Journal:  Genes Dev       Date:  2007-07-24       Impact factor: 11.361

8.  Thiazolidinediones suppress endothelin-1 secretion from bovine vascular endothelial cells: a new possible role of PPARgamma on vascular endothelial function.

Authors:  H Satoh; K Tsukamoto; Y Hashimoto; N Hashimoto; M Togo; M Hara; H Maekawa; N Isoo; S Kimura; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  1999-01-27       Impact factor: 3.575

9.  Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.

Authors:  Ling Tao; Hui-Rong Liu; Erhe Gao; Zhi-Ping Teng; Bernard L Lopez; Theodore A Christopher; Xin-Liang Ma; Ines Batinic-Haberle; Robert N Willette; Eliot H Ohlstein; Tian-Li Yue
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

10.  Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients.

Authors:  Annaswamy Raji; Ellen W Seely; Shannon A Bekins; Gordon H Williams; Donald C Simonson
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

View more
  17 in total

1.  Altered clock gene expression and vascular smooth muscle diurnal contractile variations in type 2 diabetic db/db mice.

Authors:  Wen Su; Zhongwen Xie; Zhenheng Guo; Marilyn J Duncan; Jenny Lutshumba; Ming C Gong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

2.  Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.

Authors:  J David Symons; Ping Hu; Ying Yang; Xiaohui Wang; Quan-Jiang Zhang; Adam R Wende; Crystal L Sloan; Sandra Sena; E Dale Abel; Sheldon E Litwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 3.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

4.  Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity.

Authors:  Ding Zhao; Belinda H McCully; Virginia L Brooks
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

Review 5.  Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.

Authors:  Pimonrat Ketsawatsomkron; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

6.  Fasting-induced reductions in cardiovascular and metabolic variables occur sooner in obese versus lean mice.

Authors:  Jason M Tanner; Devin T Kearns; Bum Jun Kim; Crystal Sloan; Zhanjun Jia; Tianxin Yang; E Dale Abel; J David Symons
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

Review 7.  Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.

Authors:  Salman Azhar
Journal:  Future Cardiol       Date:  2010-09

8.  Effect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance.

Authors:  Madeliene Stump; Deng-Fu Guo; Ko-Ting Lu; Masashi Mukohda; Xuebo Liu; Kamal Rahmouni; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

9.  PPARs in the Renal Regulation of Systemic Blood Pressure.

Authors:  Tamás Roszer; Mercedes Ricote
Journal:  PPAR Res       Date:  2010-06-08       Impact factor: 4.964

10.  PPARgamma Agonists: Blood Pressure and Edema.

Authors:  Bonnie L Blazer-Yost
Journal:  PPAR Res       Date:  2009-12-22       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.